恩华药业(002262.SZ)拟推2024年限制性股票激励计划

智通财经网06-12

智通财经APP讯，恩华药业(002262.SZ)发布2024年限制性股票激励计划(草案)，拟向激励对象授予的限制性股票数量为876.16万股，约占本次激励计划草案公告时公司股本总额的0.8696%。授予价格为11.51元/股。本次激励计划激励对象总人数为860人，激励计划有效期自限制性股票授予登记完成之日起至激励对象获授的限制性股票全部解除限售或回购注销完成之日止，最长不超过48个月。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2442534750?lang=zh_CN&edition=full","thumbnail":"https://img.zhitongcaijing.com/astock/10.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","is_english":false,"pubTime":"2024-06-12 19:01","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2442534750","market":"sh","top_or_hot":-1,"title":"恩华药业(002262.SZ)拟推2024年限制性股票激励计划","media":"智通财经网","content":"<div>\n<p>智通财经APP讯，恩华药业(002262.SZ)发布2024年限制性股票激励计划(草案)，拟向激励对象授予的限制性股票数量为876.16万股，约占本次激励计划草案公告时公司股本总额的0.8696%。授予价格为11.51元/股。本次激励计划激励对象总人数为860人，激励计划有效期自限制性股票授予登记完成之日起至激励对象获授的限制性股票全部解除限售或回购注销完成之日止，最长不超过48个月。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1134315.html\">网页链接</a>\n\n</div>\n","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恩华药业(002262.SZ)拟推2024年限制性股票激励计划</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恩华药业(002262.SZ)拟推2024年限制性股票激励计划\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-12 19:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1134315.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，恩华药业(002262.SZ)发布2024年限制性股票激励计划(草案)，拟向激励对象授予的限制性股票数量为876.16万股，约占本次激励计划草案公告时公司股本总额的0.8696%。授予价格为11.51元/股。本次激励计划激励对象总人数为860人，激励计划有效期自限制性股票授予登记完成之日起至激励对象获授的限制性股票全部解除限售或回购注销完成之日止，最长不超过48个月。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1134315.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"002262","symbol_name":"恩华药业","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1134315.html","article_id":"2442534750","we_media_id":null,"thumbnails":["https://img.zhitongcaijing.com/astock/10.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2442534750","pubTimestamp":1718190063,"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"恩华药业(002262.SZ)发布2024年限制性股票激励计划(草案)，拟向激励对...","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"002262":"恩华药业","BK0188":"融资融券","BK0070":"员工持股","BK0239":"医药制造"},"translate_title":"Nhua Pharmaceuticals (002262. SZ) plans to launch a restricted stock incentive plan for 2024","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002262":1},"content_text":"智通财经APP讯，恩华药业(002262.SZ)发布2024年限制性股票激励计划(草案)，拟向激励对象授予的限制性股票数量为876.16万股，约占本次激励计划草案公告时公司股本总额的0.8696%。授予价格为11.51元/股。本次激励计划激励对象总人数为860人，激励计划有效期自限制性股票授予登记完成之日起至激励对象获授的限制性股票全部解除限售或回购注销完成之日止，最长不超过48个月。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2442534750"}